J.T. Miller and the Rangers are back together again after an absence of nearly seven years, in which New York’s one-time, ...

The FDA has approved a third biosimilar for tocilizumab, called Avtozma, the second such biosimilar to be available in both ...

UCB, a global biopharmaceutical company, today announced the CHMP (Committee for Medicinal Products for Human Use) has issued a positive opinion for the self-administration of RYSTIGGO® ...

CAR T cell therapy is one of the most promising new cancer treatments to emerge in recent years. It involves removing a ...

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Neuraxpharm Ireland, part of Neuraxpharm Group, a leading European speciality pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, today announced the launch of ...

A clinical trial supported by the National Institutes of Health (NIH) is testing an experimental treatment designed to help people suffering the effects of dengue, a mosquito-borne viral disease.

Bristol Myers Squibb today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of Breyanzi® (lisocabtagene maraleucel; ...

KOLKATA: Bengal health department on Friday recalled all types of saline and several drugs manufactured and supplied by ...

CIH leadership has participated in multiple meetings with regional and state legislators to address financial inequity faced ...

The tour of the cancer center was led by Joel Beiswenger, and included CentraCare health care professionals, Astera Health ...